Monoclonal gammopathy of undetermined significance other diagnostic studies: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Monoclonal gammopathy of undetermined significance | {{Monoclonal gammopathy of undetermined significance}} | ||
{{CMG}}; {{AE}} {{OK}} | |||
==Overview== | |||
==Overview== | ==Overview== | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Revision as of 16:35, 13 August 2018
|
Monoclonal gammopathy of undetermined significance Microchapters |
|
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Monoclonal gammopathy of undetermined significance other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance other diagnostic studies |
|
FDA on Monoclonal gammopathy of undetermined significance other diagnostic studies |
|
on Monoclonal gammopathy of undetermined significance other diagnostic studies |
|
Monoclonal gammopathy of undetermined significance other diagnostic studies in the news |
|
Blogs on Monoclonal gammopathy of undetermined significance other diagnostic studies |
|
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Overview
Other Diagnostic Studies
Protein Electrophoresis
The protein electrophoresis test should be repeated annually, and if there is any concern for a rise in the level of monoclonal protein, then prompt referral to a haematologist is required.
Bone Marrow Biopsy
A bone marrow biopsy should be performed.